Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide.
El Fakiri M, Regupathy AR, Uhlmann L, Ayada N, Geis NM, Domogalla LC, Lahdenranta J, Blakeman B, Wood F, Meyer PT, Huxley P, Eder M, Mudd GE, Eder AC.
El Fakiri M, et al. Among authors: uhlmann l.
Theranostics. 2024 Aug 6;14(12):4701-4712. doi: 10.7150/thno.96641. eCollection 2024.
Theranostics. 2024.
PMID: 39239524
Free PMC article.